880 related articles for article (PubMed ID: 16287615)
1. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
Koda M; Banno Y; Naganawa T
Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tyrosine kinase activity prevents the adhesive and cohesive properties of platelets and the expression of procoagulant activity in response to collagen.
Diaz-Ricart M; Palomo M; Fuste B; Lopez-Vilchez I; Carbo C; Perez-Pujol S; White JG; Escolar G
Thromb Res; 2008; 121(6):873-83. PubMed ID: 17904203
[TBL] [Abstract][Full Text] [Related]
3. Platelet 12-lipoxygenase activation via glycoprotein VI: involvement of multiple signaling pathways in agonist control of H(P)ETE synthesis.
Coffey MJ; Jarvis GE; Gibbins JM; Coles B; Barrett NE; Wylie OR; O'Donnell VB
Circ Res; 2004 Jun; 94(12):1598-605. PubMed ID: 15142951
[TBL] [Abstract][Full Text] [Related]
4. Junctional adhesion molecule (JAM) is phosphorylated by protein kinase C upon platelet activation.
Ozaki H; Ishii K; Arai H; Horiuchi H; Kawamoto T; Suzuki H; Kita T
Biochem Biophys Res Commun; 2000 Oct; 276(3):873-8. PubMed ID: 11027562
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
[TBL] [Abstract][Full Text] [Related]
6. The effect of anticoagulants and the role of thrombin on neutrophil-endothelial cell interactions in septic shock.
Tsen A; Kirschenbaum LA; LaRow C; Khan R; Kurtz S; Bansal S; Astiz ME
Shock; 2009 Feb; 31(2):120-4. PubMed ID: 18636042
[TBL] [Abstract][Full Text] [Related]
7. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin modulates platelet activation in vitro through protein-tyrosine phosphorylation.
Kubota Y; Arai T; Tanaka T; Yamaoka G; Kiuchi H; Kajikawa T; Kawanishi K; Ohnishi H; Yamaguchi M; Takahara J; Irino S
Stem Cells; 1996 Jul; 14(4):439-44. PubMed ID: 8843545
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase blockers: new platelet activation inhibitors.
Rendu F; Eldor A; Grelac F; Levy-Toledano S; Levitzki A
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):713-6. PubMed ID: 2133252
[TBL] [Abstract][Full Text] [Related]
10. Platelet enhancement of O2-. responses in stimulated human neutrophils. Identification of platelet factor as adenine nucleotide.
Ward PA; Cunningham TW; McCulloch KK; Phan SH; Powell J; Johnson KJ
Lab Invest; 1988 Jan; 58(1):37-47. PubMed ID: 2826882
[TBL] [Abstract][Full Text] [Related]
11. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses.
Nakashima S; Koike T; Nozawa Y
Mol Pharmacol; 1991 Apr; 39(4):475-80. PubMed ID: 2017148
[TBL] [Abstract][Full Text] [Related]
12. The tyrosine kinase inhibitors, genistein and methyl 2,5-dihydroxycinnamate, inhibit the release of (3H)arachidonate from human platelets stimulated by thrombin or collagen.
Hargreaves PG; Licking EF; Sargeant P; Sage SO; Barnes MJ; Farndale RW
Thromb Haemost; 1994 Oct; 72(4):634-42. PubMed ID: 7878644
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
Wang WY; Hsieh PW; Wu YC; Wu CC
Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
[TBL] [Abstract][Full Text] [Related]
14. Efficient tyrosine phosphorylation of proteins after activation of platelets with thrombin depends on intact glycoprotein Ib.
Diaz-Ricart M; Fuste B; Estebanell E; Tonda R; Lozano M; Escolar G; Jamieson G; Ordinas A
Platelets; 2005 Dec; 16(8):453-61. PubMed ID: 16287612
[TBL] [Abstract][Full Text] [Related]
15. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
16. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
17. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
Martinson EA; Scheible S; Marx-Grunwitz A; Presek P
Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
[TBL] [Abstract][Full Text] [Related]
18. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation.
Shen EC; Chou TC; Gau CH; Tu HP; Chen YT; Fu E
Clin Oral Implants Res; 2006 Oct; 17(5):572-8. PubMed ID: 16958699
[TBL] [Abstract][Full Text] [Related]
19. Detection of activated platelets and platelet-leukocyte aggregates in horses.
Weiss DJ; Evanson OA
Am J Vet Res; 1997 Aug; 58(8):823-7. PubMed ID: 9256963
[TBL] [Abstract][Full Text] [Related]
20. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]